








|
| Investment Strategy |
|
| The Chesapeake Growth Fund seeks capital appreciation
through investments in small, medium and large capitalization growth
equities. The cornerstone of the Fund's intensive in-house fundamental
analysis is constant contact with the management, customers, competitors
and suppliers of both current and potential investments. |
 |
|
 |
| Goodrich Petroleum Corporation |
4.9% |
| Consol Energy, Inc. |
3.6% |
| Google, Inc. C1-A |
3.5% |
| Monsanto Company |
3.4% |
| MEMC Electronic Materials, Inc |
3.3% |
| Millicom International Cellular,
S.A. |
2.7% |
| Shaw Group Inc. |
2.5% |
| Symmetry Medical, Inc. |
2.4% |
| Crown Holdings, Inc. |
2.4% |
| Range Resources Corp. |
2.3% |
To
obtain a complete listing of the Fund's portfolio of holdings as
of the most recent quarter-end, please click
here.
All
holdings information is provided for informational purposes only
and should not be deemed as a recommendation to buy the securities
mentioned. The holdings information represents the largest holdings,
by market value, in the Fund as of the most recent quarter end.
Each quarter, the Fund's Adviser uses this same objective, non-performance
based criteria to select the ten largest holdings.
|
|
| Information Technology |
31.2% |
| Consumer Discretionary |
14.7% |
| Industrials |
12.9% |
| Financials |
12.4% |
| Energy |
10.8% |
| Health Care |
8.5% |
| Materials |
5.8% |
| Telecommunication Services |
2.7% |
| Consumer Staples |
0.0% |
| Cash & Equivalents |
1.1% |

| Number of Positions |
51 |
| Median Market Cap (in bil) |
$4.8 |
| P/E Ratio - 2008 Earnings Estimates |
20x |
*Source: Baseline Financial Services
|
|
|
|
|
1
Year |
5
Year |
10
Year |
| The
Chesapeake Growth Fund Series A |
-4.93% |
11.22% |
3.52% |
Total Gross Expense Ratio as of
10/31/07 was 3.21%.
Net Expense Ratio as of 10/31/07 was 3.15%.
The Fund has entered into brokerage/service
arrangements with several brokers through commission recapture programs
(e.g., a program where a portion of the brokerage commissions paid on
portfolio transactions to a broker is returned directly to the Fund).
These portions are then used to offset overall Fund expenses. There can
be no assurance that these arrangements will continue in the future. For
more information, please see the prospectus.
| Performance
shown is for the period ended June 30, 2008. The performance data
quoted above represents past performance, which is not a guarantee
of future results. Investment return and principal value of an investment
will fluctuate so that an investor’s shares, when redeemed,
may be worth more or less than their original cost. Current performance
may be lower or higher than the performance data quoted. To obtain
more current performance data regarding the Fund, including performance
data current to the Fund’s most recent month-end, please click
here.
Historical performance has
been calculated by using the performance of the original Fund class
(now called the Institutional Shares) from inception on 4/6/94 until
the date of issuance of the Class A Shares on 4/7/95. During part
of the period cited the adviser assumed certain expenses and/or
waived a portion of its fee. Total return would have been lower
absent such assumptions or fee waivers. These fee waivers and/or
reimbursements are believed not to have had a significant effect
on the Fund's performance.
1 The maximum sales load for the Fund is 3%.
Investment in the Fund is subject
to investment risks, including, without limitation, equity securities
risk, market risk, internal change risk, medium capitalization risk,
portfolio turnover risk, short-term investment risk, investment
adviser risk, and overweighting in certain market sectors risk.
As an investor in the Fund, you are subject to the risk that you
may lose your money as a result of the impact of the Fund’s
investment risk on the Fund’s net asset value per share. When
you sell your investment in the Fund, the value of your investment
may be more or less than your initial investment.
An investor should
consider the investment objectives, risks, and charges and expenses
of the Fund carefully before investing. The prospectus
contains this and other information about the Fund. A copy of the
prospectus is available by calling the Fund directly at (800) 430-3863
or the Fund’s adviser at (610)
558-2800. The prospectus should be read carefully before investing.
|
|
Underwriter
and Distributor
Ultimus Fund Distributors, LLC
225 Pictoria Drive, Suite 450
Cincinnati, OH 45246
Phone (800) 430-3863 |
The Fund
is available for sale in the following states:
AL, CA, CO, CT, DE, FL, GA, IL, IN, LA, MA, MD, MN, MS,
NC, NY, OH, PA, RI, SC, TN, TX, VA, WA, WY |
|